Caribou Biosciences
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Caribou Biosciences's balance sheet done over the years? Its assets were worth $432,209,000 last year, which is more than in the previous period. 15% of Caribou Biosciences’s total assets is currently financed by debt. Its liabilities reached the amount of $63,808,000, which means an decrease by -12% compared compared to last year.

Debt to Assets

Caribou Biosciences, Inc. (NASDAQ:CRBU): Debt to assets
2019 61933000 54.47M 87.95%
2020 36046000 59.48M 165.02%
2021 442356000 54.53M 12.33%
2022 373765000 72.89M 19.5%
2023 432209000 63.80M 14.76%

CRBU Balance Sheet (2019 – 2023)

2023 2022 2021 2020 2019
Assets
Current assets:
Cash and cash equivalents
51.16M58.33M240.42M15.95M41.07M
Short term investments
277.66M189.32M135.41M08.40M
Net receivables
3.85M4.66M8.12M5.16M3.98M
Inventory
0-62.57M-31.11M2.43M3.18M
Other current assets
6.15M1.11M671K760K373K
Total current assets
338.84M260.24M391.19M24.30M57.00M
Non-current assets:
Property, Plant and Equipment
40.45M34.90M4.88M3.50M4.33M
Goodwill
00000
Intangible assets
00000
Long term investments
51.33M77.07M45.30M7.62M0
Other non-current assets
1.58M1.53M975K612K593K
Total non-current assets
93.36M113.51M51.16M11.74M4.92M
Total assets
432.20M373.76M442.35M36.04M61.93M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
2.84M9.93M8.70M161K717K
Short term debt
1.2M966K12.34M654K532K
Total current liabilities
28.30M28.12M25.82M12.38M10.07M
Non-current liabilities:
Long term debt
25.90M26.78M2.09M924K42.22M
Deferred tax
00000
Other non-current liabilities
2.93M1.65M4.09M45.07M533K
Total non-current liabilities
35.50M44.76M28.70M47.09M44.39M
Total liabilities
63.80M72.89M54.53M59.48M54.47M
Data sourceData sourceData source